{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:48:09Z","timestamp":1782193689950,"version":"3.54.5"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Myocarditis is an inflammatory disease of the myocardium with heterogeneous aetiologies, in which innate and adaptive immune responses critically influence clinical outcomes, ranging from complete recovery to progression toward dilated cardiomyopathy. In viral myocarditis, pathogen- and damage-associated molecular patterns activate pattern-recognition receptors, triggering NF-\n                    <jats:italic>\u03ba<\/jats:italic>\n                    B and inflammasome signaling and amplifying pro-inflammatory cytokine responses. Early myocardial injury involves neutrophils, mast cells, natural killer cells, and inflammatory monocytes, followed by activation of adaptive immune responses. Imbalance of Th1\/Th2 immunity and dysregulation of the Th17\/Treg axis promote persistent inflammation and fibrotic remodeling. Autoimmune mechanisms driven by molecular mimicry, pathogenic autoantibodies, and genetic susceptibility further sustain myocardial injury. While conventional biomarkers support diagnosis, emerging inflammatory markers and immune-derived indices show promise for risk stratification and disease monitoring. Beyond guideline-directed heart failure therapy, targeted immunomodulatory strategies are under investigation, highlighting the need for precision approaches to prevent chronic inflammation and adverse remodeling.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2026.1821475","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:26:35Z","timestamp":1782192395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Myocardial inflammation in myocarditis: mechanisms and therapeutic targets"],"prefix":"10.3389","volume":"13","author":[{"given":"Cristina","family":"Madaudo","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Lisi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Macaione","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Nuzzi","sequence":"additional","affiliation":[{"name":"Department of Clinical Cardiology and Heart Failure, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, IRCCS ISMETT, UPMC","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Micarelli","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Sausa","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Castelli","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Corrado","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]},{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Ruggero","family":"Galassi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]},{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Novo","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo","place":["Palermo, Italy"]},{"name":"Division of Cardiology, University Hospital P. Giaccone, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJMra2114478","article-title":"Myocarditis","volume":"387","author":"Basso","year":"2022","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3390\/ijms25116016","article-title":"Discovering inflammation in atherosclerosis: insights from pathogenic pathways to clinical practice","volume":"25","author":"Madaudo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcvm.2019.00048","article-title":"Cardio-Immunology of myocarditis: focus on immune mechanisms and treatment options","volume":"6","author":"Maisch","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2025.12.004","article-title":"Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics","volume":"119","author":"Chen","year":"2026","journal-title":"Semin Cancer Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s11427-022-2273-3","article-title":"Immunopathogenesis and immunomodulatory therapy for myocarditis","volume":"66","author":"He","year":"2023","journal-title":"Sci China Life Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","article-title":"Detection of viruses in myocardial tissues by polymerase chain reaction","volume":"42","author":"Bowles","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction","volume":"111","author":"K\u00fchl","year":"2005","journal-title":". Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/biology12060874","article-title":"Myocarditis: etiology, pathogenesis, and their implications in clinical practice","volume":"12","author":"Brociek","year":"2023","journal-title":"Biology (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circ: Heart Failure"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/biomedicines12061156","article-title":"The role of the immune system in pathobiology and therapy of myocarditis: a review","volume":"12","author":"Vicenzetto","year":"2024","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases","volume":"34","author":"Caforio","year":"","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume-title":"The Immunology of Cardiovascular Homeostasis and Pathology","author":"Bracamonte-Baran","year":"2017"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-Associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"key":"B15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1149911","DOI":"10.3389\/fcimb.2023.1149911","article-title":"Roles of inflammasomes in viral myocarditis","volume":"13","author":"Xu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3389\/fimmu.2018.02171","article-title":"Update on neutrophil function in severe inflammation","volume":"9","author":"Mortaz","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9575373","article-title":"Heparin-Binding protein: a novel biomarker linking four different cardiovascular diseases","volume":"2020","author":"Cai","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1161\/CIRCULATIONAHA.105.572396","article-title":"Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1\u03b1 in induction of experimental autoimmune myocarditis and effective anti\u2013monocyte chemoattractant protein-1 gene therapy","volume":"112","author":"G\u00f6ser","year":"2005","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0182643","DOI":"10.1371\/journal.pone.0182643","article-title":"CX3CR1 Knockout aggravates coxsackievirus B3-induced myocarditis","volume":"12","author":"M\u00fcller","year":"2017","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.3390\/ijms25115579","article-title":"TGF-\u03b2 Signalling regulates cytokine production in inflammatory cardiac macrophages during experimental autoimmune myocarditis","volume":"25","author":"Tkacz","year":"2024","journal-title":"IJMS"},{"key":"B23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.celrep.2019.06.007","article-title":"The cardiac microenvironment instructs divergent monocyte fates and functions in myocarditis","volume":"28","author":"Hou","year":"2019","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0002-9440(10)63241-5","article-title":"Interferon-\u03b3 protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-\u03b21, interleukin-1\u03b2, and interleukin-4 in the heart","volume":"165","author":"Fairweather","year":"2004","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"85851","DOI":"10.1172\/jci.insight.85851","article-title":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis","volume":"1","author":"Myers","year":"2016","journal-title":"JCI Insight"},{"key":"B26","doi-asserted-by":"publisher","first-page":"156691","DOI":"10.1016\/j.cyto.2024.156691","article-title":"IL-17 signaling pathway: a potential therapeutic target for reducing skeletal muscle inflammation","volume":"181","author":"Liu","year":"2024","journal-title":"Cytokine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","article-title":"Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis","volume":"145","author":"Ammirati","year":"2022","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1388-9842(02)00010-7","article-title":"Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance","volume":"4","author":"Caforio","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.4049\/jimmunol.177.11.8234","article-title":"Mimicry and antibody-mediated cell signaling in autoimmune myocarditis","volume":"177","author":"Li","year":"2006","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI21748","article-title":"Anti\u2013\u03b21-adrenergic receptor antibodies and heart failure: causation, not just correlation","volume":"113","author":"Freedman","year":"2004","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ebiom.2019.08.045","article-title":"Cardiac troponin I autoantibody induces myocardial dysfunction by PTEN signaling activation","volume":"47","author":"Wu","year":"2019","journal-title":"EBioMedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/eji.201142104","article-title":"Autoimmunity against M2 muscarinic acetylcholine receptor induces myocarditis and leads to a dilated cardiomyopathy-like phenotype","volume":"42","author":"Yoshizawa","year":"2012","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11886-020-01278-1","article-title":"Autoimmunity in acute myocarditis: how immunopathogenesis steers new directions for diagnosis and treatment","volume":"22","author":"Bruestle","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1002\/iid3.1237","article-title":"CXCL4\/CXCR3 Axis regulates cardiac fibrosis by activating TGF-\u03b21\/Smad2\/3 signaling in mouse viral myocarditis","volume":"12","author":"Wei","year":"2024","journal-title":"Immunity Inflam and Disease"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.3390\/jcm12237214","article-title":"Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: an updated review of the literature","volume":"12","author":"Crisci","year":"2023","journal-title":"J Clin Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e031454","DOI":"10.1161\/JAHA.123.031454","article-title":"Diagnostic approach for suspected acute myocarditis: considerations for standardization and broadening clinical Spectrum","volume":"12","author":"Martens","year":"2023","journal-title":"JAHA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.3390\/jcm11237068","article-title":"A machine-learning model for the prognostic role of C-reactive protein in myocarditis","volume":"11","author":"Baritussio","year":"2022","journal-title":"JCM"},{"key":"B39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jchf.2024.11.003","article-title":"Elevated neutrophil-to-lymphocyte ratio predicts prognosis in acute myocarditis","volume":"13","author":"Cannata","year":"2025","journal-title":"JACC Heart Fail"},{"key":"B40","doi-asserted-by":"publisher","first-page":"ejhf.70072","DOI":"10.1002\/ejhf.70072","article-title":"Neutrophil-to-lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum","volume":"16","author":"Madaudo","year":"2025","journal-title":"European J of Heart Fail"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.17219\/acem\/126049","article-title":"Clinical value of soluble ST2 in cardiology","volume":"29","author":"Dudek","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/jcm12123970","article-title":"Prognostic value of sST2 in heart failure","volume":"12","author":"Sciatti","year":"2023","journal-title":"JCM"},{"key":"B43","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12967-023-04782-4","article-title":"Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives","volume":"21","author":"Zhou","year":"2023","journal-title":"J Transl Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ehf2.12760","article-title":"Serum alarmin S100A8\/S100A9 levels and its potential role as biomarker in myocarditis","volume":"7","author":"M\u00fcller","year":"2020","journal-title":"ESC Heart Failure"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.jacc.2016.09.937","article-title":"The quest for new approaches in myocarditis and inflammatory cardiomyopathy","volume":"68","author":"Heymans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11886-018-1054-z","article-title":"Acute and fulminant myocarditis: a pragmatic clinical approach to diagnosis and treatment","volume":"20","author":"Ammirati","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","article-title":"Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis","volume":"136","author":"Ammirati","year":"2017","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-020-00360-y","article-title":"Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes","volume":"5","author":"Hang","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.cpcardiol.2023.102229","article-title":"Management of cancer patients at high and very-high risk of cardiotoxicity: main questions and answers","volume":"49","author":"Di Lisi","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e013757","DOI":"10.1161\/JAHA.119.013757","article-title":"Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment","volume":"9","author":"Palaskas","year":"2020","journal-title":"JAHA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11886-023-01915-5","article-title":"Role of biomarkers in the management of immune-checkpoint inhibitor-related myocarditis","volume":"25","author":"Vasbinder","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pcad.2022.10.004","article-title":"Myocarditis associated with COVID-19 and its vaccines\u2014a systematic review","volume":"74","author":"Rout","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.123.321878","article-title":"COVID-19, myocarditis and pericarditis","volume":"132","author":"Fairweather","year":"2023","journal-title":"Circ Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"H1059","DOI":"10.1152\/ajpheart.00681.2020","article-title":"Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection","volume":"319","author":"Robinson","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"102823","DOI":"10.1016\/j.cpcardiol.2024.102823","article-title":"SGLT2 Inhibitor therapy in patients with advanced heart failure and reduced ejection fraction","volume":"49","author":"Nuzzi","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/FJC.0000000000001542","article-title":"Current treatment and immunomodulation strategies in acute myocarditis","volume":"83","author":"Ferone","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"ehae666.1239","DOI":"10.1093\/eurheartj\/ehae666.1239","article-title":"Rationale and study design of the international randomized control trial MYocarditis THerapy with steroids: the MYTHS trial","volume":"45","author":"Ammirati","year":"2024","journal-title":"Eur Heart J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.acvd.2023.07.004","article-title":"Rationale and design of the ARAMIS trial: anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis","volume":"116","author":"Kerneis","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ehjacc\/zuad102","article-title":"In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis","volume":"12","author":"Morrow","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1821475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:26:36Z","timestamp":1782192396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1821475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":60,"alternative-id":["10.3389\/fcvm.2026.1821475"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1821475","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1821475"}}